$5.64
1.57% yesterday
Nasdaq, May 14, 10:00 pm CET
ISIN
US67092M2089
Symbol
NTRB
Sector

Nutriband Stock price

$5.64
+0.68 13.71% 1M
+0.75 15.34% 6M
+0.93 19.75% YTD
+1.93 52.06% 1Y
+2.20 64.09% 3Y
-3.19 36.12% 5Y
-0.02 0.30% 10Y
Nasdaq, Closing price Wed, May 14 2025
-0.09 1.57%
ISIN
US67092M2089
Symbol
NTRB
Sector

Key metrics

Market capitalization $63.91m
Enterprise Value $59.79m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 27.94
P/S ratio (TTM) P/S ratio 29.86
P/B ratio (TTM) P/B ratio 9.87
Revenue growth (TTM) Revenue growth 2.60%
Revenue (TTM) Revenue $2.14m
EBIT (operating result TTM) EBIT $-6.69m
Free Cash Flow (TTM) Free Cash Flow $-4.72m
Cash position $4.31m
EPS (TTM) EPS $-0.98
P/S forward 4.61
EV/Sales forward 4.31
Short interest 3.57%
Show more

Is Nutriband a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Nutriband Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Nutriband:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Nutriband:

Buy
100%

Financial data from Nutriband

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
2.14 2.14
2% 2%
100%
- Direct Costs 1.44 1.44
13% 13%
67%
0.70 0.70
15% 15%
33%
- Selling and Administrative Expenses 3.98 3.98
16% 16%
186%
- Research and Development Expense 3.12 3.12
59% 59%
146%
-6.40 -6.40
40% 40%
-299%
- Depreciation and Amortization 0.29 0.29
3% 3%
14%
EBIT (Operating Income) EBIT -6.69 -6.69
37% 37%
-313%
Net Profit -10 -10
91% 91%
-490%

In millions USD.

Don't miss a Thing! We will send you all news about Nutriband directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nutriband Stock News

Neutral
GlobeNewsWire
15 days ago
ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2024 and the potential outlook for 2025.
Neutral
GlobeNewsWire
about one month ago
ORLANDO, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received notification that its patent has been granted in Macao for its patent entitled, "Abuse and Misuse Deterrent Transdermal Systems," which protects its AVERSA™ abuse deterrent tra...
Neutral
GlobeNewsWire
about one month ago
ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC.
More Nutriband News

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.

Head office United States
CEO Gareth Sheridan
Founded 2012
Website www.nutriband.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today